Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionWealthfront Inc
Latest Disclosed Ownership18,382 shares
Latest Disclosed Value $ 1,419,000
Wealthfront Inc reports 6.94% increase in ownership of GILD / Gilead Sciences, Inc.

On April 30, 2019 - Wealthfront Inc filed a 13F-HR/A form disclosing ownership of 18,382 shares of Gilead Sciences, Inc. (US:GILD) valued at $1,419,274 USD as of September 30, 2018. The entity filed a previous 13F-HR/A on April 30, 2019 disclosing 17,189 shares of Gilead Sciences, Inc.. This represents a change in shares of 6.94% during the quarter. The current value of the position is $2,371,094 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2019-04-30 2018-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 18,382 1,193 6.94 1,419 16.50 0.0137
2018-11-13 2018-09-30 13F GILEAD SCIENCES INC COM COM 375558103 18,382 1,193 1,419
2019-04-30 2018-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 17,189 -10,264 -37.39 1,218 -41.16 0.0124
2018-08-10 2018-06-30 13F GILEAD SCIENCES INC COM COM 375558103 17,189 -10,264 1,218
2019-04-30 2018-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 27,453 5,974 27.81 2,070 34.50 0.0210
2018-05-07 2018-03-31 13F GILEAD SCIENCES INC COM COM 375558103 27,453 5,974 2,070
2019-04-30 2017-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 21,479 -1,786 -7.68 1,539 -18.36 0.0171
2018-02-09 2017-12-31 13F GILEAD SCIENCES INC COM COM 375558103 21,479 -1,786 1,539
2019-04-30 2017-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 23,265 13,007 126.80 1,885 159.64 0.0243
2017-11-14 2017-09-30 13F GILEAD SCIENCES INC COM COM 375558103 23,265 13,007 1,885
2019-05-02 2017-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 10,258 102 1.00 726 5.22 0.0109
2017-08-11 2017-06-30 13F GILEAD SCIENCES COM 375558103 10,258 102 726
2019-05-02 2017-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 10,156 865 9.31 690 3.76 0.0123
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM 375558103 10,156 865 690
2019-04-30 2016-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 9,291 -6,033 -39.37 665 -45.13 0.0146
2019-04-30 2016-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 15,324 913 6.34 1,212 0.83 0.0287
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 15,324 913 1,212
2019-04-30 2016-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 14,411 -6,941 -32.51 1,202 -38.70 0.0331
2016-08-16 2016-06-30 13F GILEAD SCIENCES COM 375558103 14,411 -6,941 1,202
2016-05-18 2016-03-31 13F GILEAD SCIENCES COM 375558103 21,352 3,750 21.30 1,961 10.11 0.0620
2016-02-17 2015-12-31 13F GILEAD SCIENCES COM 375558103 17,602 -631 -3.46 1,781 -0.50 0.0641
2015-11-18 2015-09-30 13F GILEAD SCIENCES COM 375558103 18,233 3,005 19.73 1,790 0.39 0.0716
2015-08-18 2015-06-30 13F GILEAD SCIENCES COM 375558103 15,228 5,848 62.35 1,783 93.80 0.0733
2015-05-14 2015-03-31 13F GILEAD SCIENCES COM 375558103 9,380 1,403 17.59 920 22.34 0.0442
2015-02-17 2014-12-31 13F GILEAD SCIENCES COM 375558103 7,977 -481 -5.69 752 -16.44 0.0440
2014-11-14 2014-09-30 13F GILEAD SCIENCES Common 375558103 8,458 2,412 39.89 900 69.49 0.0623
2014-07-24 2014-06-30 13F GILEAD SCIENCES Common 375558103 6,046 4,963 458.26 531 563.75 0.0460
2014-05-29 2014-03-31 13F GILEAD SCIENCES Common 375558103 1,083 1,083 80 0.0108
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.